SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis

Leuk Lymphoma. 2017 Sep;58(9):1-3. doi: 10.1080/10428194.2017.1287357. Epub 2017 Feb 9.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor*
  • DNA Mutational Analysis
  • Fatal Outcome
  • Gene Dosage
  • Genotype
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Male
  • Oncogene Proteins, Fusion / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Prognosis
  • Proto-Oncogene Proteins c-abl / genetics*
  • Sorting Nexins / genetics*
  • Translocation, Genetic

Substances

  • Biomarkers, Tumor
  • Oncogene Proteins, Fusion
  • SNX2 protein, human
  • Sorting Nexins
  • Proto-Oncogene Proteins c-abl